Premature	B-O
termination	I-LF
codons	B-O
.	B-O
Some	B-O
full-length	B-O
p53	B-O
was	B-O
produced	B-O
from	B-O
the	B-O
R213X	B-O
TP53	B-O
mRNA	B-O
in	B-O
the	B-O
absence	B-O
of	B-O
G418,	B-O
reflecting	B-O
spontaneous	B-O
readthrough.	B-O
G418	B-O
induced	B-O
PTC	B-AC
readthrough,	B-O
as	B-O
seen	B-O
by	B-O
the	B-O
increased	B-O
production	B-O
of	B-O
full-length	B-O
p53,	B-O
which	B-O
reached	B-O
a	B-O
peak	B-O
at	B-O
approximately	B-O
0.3	B-O
μM.	B-O
However,	B-O
higher	B-O
G418	B-O
concentrations	B-O
reduced	B-O
readthrough,	B-O
to	B-O
the	B-O
same	B-O
extent	B-O
as	B-O
they	B-O
inhibited	B-O
the	B-O
synthesis	B-O
of	B-O
WT	B-AC
p53	B-O
.	B-O
This	B-O
result	B-O
indicates	B-O
that	B-O
inhibition	B-O
of	B-O
protein	B-O
synthesis	B-O
puts	B-O
an	B-O
intrinsic	B-O
limitation	B-O
on	B-O
the	B-O
extent	B-O
of	B-O
PTC	B-AC
readthrough	B-O
that	B-O
can	B-O
be	B-O
elicited	B-O
by	B-O
G418,	B-O
making	B-O
PTC	B-AC
readthrough	B-O
by	B-O
G418	B-O
a	B-O
self-limiting	B-O
process.	B-O
Download:	B-O
PPT	B-O
PowerPoint	B-O
slide	B-O
PNG	B-O
larger	B-O
image	B-O
TIFF	B-O
original	B-O
image	B-O
Fig	B-O
1.	B-O
PTC	B-AC
readthrough	B-O
in	B-O
a	B-O
cell-free	B-O
translation	B-O
assay.	B-O
WT	B-AC
and	B-O
R213X	B-O
TP53	B-O
mRNAs	B-O
were	B-O
translated	B-O
in	B-O
vitro	B-O
in	B-O
the	B-O
presence	B-O
of	B-O
G418	B-O
at	B-O
the	B-O
indicated	B-O
concentrations	B-O
and	B-O
equal	B-O
amounts	B-O
of	B-O
protein	B-O
were	B-O
subjected	B-O
to	B-O
automated	B-O
capillary	B-O
electrophoresis	B-O
western	B-O
analysis.	B-O
The	B-O
data	B-O
are	B-O
displayed	B-O
as	B-O
“pseudo-blots”	B-O
of	B-O
bound	B-O
p53	B-O
antibody	B-O
chemiluminescence.	B-O
FL-p53	B-O
chemiluminescence	B-O
is	B-O
expressed	B-O
relative	B-O
to	B-O
the	B-O
maximum	B-O
value	B-O
observed	B-O
in	B-O
either	B-O
WT	B-AC
or	B-O
R213X	B-O
and	B-O
shown	B-O
under	B-O
each	B-O
lane.	B-O
Uncropped	B-O
images	B-O
of	B-O
automated	B-O
capillary	B-O
electrophoresis	B-O
western	B-O
analyses	B-O
are	B-O
provided	B-O
in	B-O
S1	B-O
Raw	B-O
Images	B-O
.	B-O
FL-p53,	B-O
full-length	B-O
p53;	B-O
PTC,	B-O
premature	B-LF
termination	I-LF
codon;	B-O
WT,	B-O
wild-type.	B-O
Identification	B-O
of	B-O
Y-320	B-O
as	B-O
a	B-O
PTC	B-AC
readthrough	B-O
enhancer	B-O
It	B-O
has	B-O
recently	B-O
been	B-O
shown	B-O
that	B-O
PTC	B-AC
readthrough	B-O
by	B-O
aminoglycosides	B-O
can	B-O
be	B-O
enhanced	B-O
by	B-O
small	B-O
molecules	B-O
that	B-O
do	B-O
not	B-O
themselves	B-O
stimulate	B-O
readthrough	B-O
when	B-O
used	B-O
as	B-O
single	B-O
agents	B-O
[	B-O
16	B-O
–	B-O
19	B-O
].	B-O
We	B-O
hypothesized	B-O
that	B-O
compounds	B-O
might	B-O
exist	B-O
that	B-O
overcome	B-O
the	B-O
self-limitation	B-O
and	B-O
increase	B-O
PTC	B-AC
readthrough	B-O
by	B-O
G418	B-O
without	B-O
further	B-O
inhibiting	B-O
protein	B-O
synthesis.	B-O
In	B-O
order	B-O
to	B-O
discover	B-O
such	B-O
compounds,	B-O
we	B-O
assayed	B-O
the	B-O
Selleck	B-O
bioactive	B-O
library	B-O
of	B-O
2658	B-O
compounds	B-O
for	B-O
enhancement	B-O
of	B-O
G418-induced	B-O
PTC	B-AC
readthrough	B-O
in	B-O
HDQ-P1	B-O
cancer	B-O
cells	B-O
carrying	B-O
homozygous	B-O
TP53	B-O
R213X	B-O
nonsense	B-LF
mutations.	B-O
Cells	B-O
seeded	B-O
in	B-O
96-well	B-O
plates	B-O
were	B-O
exposed	B-O
to	B-O
the	B-O
small	B-O
molecules	B-O
in	B-O
combination	B-O
with	B-O
50	B-O
μM	B-O
G418.	B-O
Although	B-O
much	B-O
higher	B-O
than	B-O
the	B-O
concentration	B-O
active	B-O
in	B-O
cell-free	B-O
extracts,	B-O
this	B-O
G418	B-O
concentration	B-O
is	B-O
suboptimal	B-O
in	B-O
cell	B-O
assays	B-O
as	B-O
the	B-O
plasma	B-O
membrane	B-O
imposes	B-O
a	B-O
strong	B-O
barrier	B-O
to	B-O
the	B-O
intracellular	B-O
diffusion	B-O
of	B-O
the	B-O
highly	B-O
polar	B-O
aminoglycosides.	B-O
After	B-O
72	B-O
h,	B-O
TP53	B-O
PTC	B-AC
readthrough	B-O
was	B-O
assessed	B-O
using	B-O
quantitative	B-O
automated	B-O
p53	B-O
immunofluorescence	B-O
microscopy	B-O
.	B-O
The	B-O
phenylpyrazoleanilide	B-O
Y-320	B-O
was	B-O
the	B-O
strongest	B-O
PTC	B-AC
readthrough-enhancing	B-O
compound	B-O
,	B-O
as	B-O
did	B-O
cells	B-O
treated	B-O
with	B-O
Y-320	B-O
alone	B-O
.	B-O
Exposure	B-O
to	B-O
G418	B-O
induced	B-O
a	B-O
low	B-O
level	B-O
of	B-O
readthrough	B-O
which	B-O
was	B-O
strongly	B-O
enhanced	B-O
by	B-O
increasing	B-O
concentrations	B-O
of	B-O
Y-320	B-O
.	B-O
Download:	B-O
PPT	B-O
PowerPoint	B-O
slide	B-O
PNG	B-O
larger	B-O
image	B-O
TIFF	B-O
original	B-O
image	B-O
Fig	B-O
2.	B-O
Y-320	B-O
enhances	B-O
PTC	B-AC
readthrough	B-O
by	B-O
G418	B-O
in	B-O
different	B-O
cell	B-O
lines.	B-O
.	B-O
We	B-O
similarly	B-O
measured	B-O
the	B-O
effect	B-O
of	B-O
Y-320	B-O
on	B-O
TP53	B-O
readthrough	B-O
in	B-O
H1299-R213X	B-O
cancer	B-O
cells,	B-O
which	B-O
do	B-O
not	B-O
express	B-O
p53	B-O
because	B-O
of	B-O
homozygous	B-O
deletion	B-O
of	B-O
the	B-O
TP53	B-O
gene	B-O
and	B-O
have	B-O
been	B-O
stably	B-O
transfected	B-O
with	B-O
TP53	B-O
R213X	B-O
construct	B-O
.	B-O
No	B-O
full-length	B-O
p53	B-O
was	B-O
detected	B-O
in	B-O
untreated	B-O
cells	B-O
or	B-O
cells	B-O
treated	B-O
with	B-O
Y-320	B-O
alone.	B-O
G418	B-O
induced	B-O
p53	B-O
readthrough	B-O
that	B-O
was	B-O
considerably	B-O
enhanced	B-O
by	B-O
Y-320	B-O
.	B-O
To	B-O
determine	B-O
whether	B-O
Y-320	B-O
can	B-O
also	B-O
enhance	B-O
the	B-O
PTC	B-AC
readthrough	B-O
of	B-O
additional	B-O
genes,	B-O
we	B-O
next	B-O
tested	B-O
it	B-O
in	B-O
DMD	B-AC
patient-derived	B-O
myoblasts	B-O
harboring	B-O
a	B-O
nonsense	B-LF
mutation	B-O
in	B-O
the	B-O
DMD	B-AC
gene	B-O
.	B-O
Exposure	B-O
of	B-O
DMD	B-AC
cells	B-O
to	B-O
G418	B-O
during	B-O
the	B-O
differentiation	B-O
period	B-O
led	B-O
to	B-O
some	B-O
dystrophin	B-O
expression	B-O
and	B-O
cotreatment	B-O
with	B-O
Y-320	B-O
enhanced	B-O
readthrough	B-O
2.2-fold	B-O
over	B-O
G418	B-O
alone	B-O
.	B-O
The	B-O
level	B-O
of	B-O
dystrophin	B-O
in	B-O
DMD	B-AC
cells	B-O
exposed	B-O
to	B-O
1	B-O
μM	B-O
Y-320	B-O
+	B-O
G418	B-O
was	B-O
1.4%	B-O
of	B-O
that	B-O
of	B-O
WT	B-AC
myoblasts.	B-O
We	B-O
also	B-O
examined	B-O
the	B-O
effect	B-O
of	B-O
Y-320	B-O
on	B-O
Junctional	B-LF
Epidermolysis	I-LF
Bullosa	I-LF
.	B-O
Untreated	B-O
JEB	B-AC
cells	B-O
showed	B-O
no	B-O
detectable	B-O
signal	B-O
.	B-O
At	B-O
30	B-O
μM,	B-O
G418	B-O
induced	B-O
detectable	B-O
PTC	B-AC
readthrough	B-O
which	B-O
was	B-O
enhanced	B-O
3.7-fold	B-O
in	B-O
combination	B-O
with	B-O
1	B-O
μM	B-O
Y-320,	B-O
to	B-O
about	B-O
0.06%	B-O
of	B-O
levels	B-O
observed	B-O
in	B-O
HaCat	B-O
cells	B-O
.	B-O
These	B-O
results	B-O
show	B-O
that	B-O
Y-320	B-O
can	B-O
enhance	B-O
PTC	B-AC
readthrough	B-O
by	B-O
G418	B-O
in	B-O
patient-derived	B-O
cell	B-O
types	B-O
with	B-O
nonsense	B-LF
mutations	B-O
in	B-O
different	B-O
genes.	B-O
One	B-O
possible	B-O
mechanism	B-O
for	B-O
readthrough	B-O
enhancement	B-O
is	B-O
stabilization	B-O
of	B-O
mRNAs	B-O
bearing	B-O
nonsense	B-LF
mutations	B-O
via	B-O
inhibition	B-O
of	B-O
nonsense	B-LF
mediated	I-LF
decay	I-LF
.	B-O
In	B-O
combination	B-O
with	B-O
G418,	B-O
Y-320	B-O
increased	B-O
TP53	B-O
mRNA	B-O
levels	B-O
up	B-O
to	B-O
7-fold	B-O
at	B-O
2	B-O
μM	B-O
compared	B-O
to	B-O
G418	B-O
alone	B-O
,	B-O
likely	B-O
a	B-O
consequence	B-O
of	B-O
increased	B-O
PTC	B-AC
readthrough,	B-O
which	B-O
shields	B-O
the	B-O
mRNA	B-O
from	B-O
recognition	B-O
by	B-O
NMD	B-AC
[	B-O
16	B-O
,	B-O
17	B-O
].	B-O
Additionally,	B-O
in	B-O
the	B-O
cell-free	B-O
translation	B-O
assay,	B-O
G418	B-O
induced	B-O
R213X	B-O
TP53	B-O
PTC	B-AC
readthrough	B-O
but	B-O
Y-320	B-O
did	B-O
not	B-O
enhance	B-O
readthrough	B-O
,	B-O
indicating	B-O
that	B-O
unlike	B-O
G418,	B-O
Y-320	B-O
likely	B-O
does	B-O
not	B-O
directly	B-O
target	B-O
translating	B-O
ribosomes.	B-O
Effect	B-O
of	B-O
Y-320	B-O
on	B-O
protein	B-O
synthesis	B-O
The	B-O
increased	B-O
readthrough	B-O
activity	B-O
of	B-O
aminoglycosides	B-O
has	B-O
been	B-O
shown	B-O
to	B-O
correlate	B-O
with	B-O
their	B-O
inhibitory	B-O
effects	B-O
on	B-O
protein	B-O
synthesis	B-O
.	B-O
Having	B-O
discovered	B-O
that	B-O
Y-320	B-O
can	B-O
enhance	B-O
PTC	B-AC
readthrough,	B-O
we	B-O
asked	B-O
whether	B-O
it	B-O
would	B-O
adversely	B-O
affect	B-O
cellular	B-O
protein	B-O
levels	B-O
or	B-O
protein	B-O
synthesis.	B-O
We	B-O
examined	B-O
the	B-O
effects	B-O
of	B-O
Y-320	B-O
on	B-O
protein	B-O
levels	B-O
using	B-O
the	B-O
SYPRO	B-O
Ruby	B-O
protein	B-O
stain.	B-O
SYPRO	B-O
Ruby,	B-O
a	B-O
fluorescent	B-O
dye	B-O
that	B-O
labels	B-O
positively	B-O
charged	B-O
amino	B-O
acids	B-O
and	B-O
therefore	B-O
most	B-O
classes	B-O
of	B-O
proteins	B-O
in	B-O
the	B-O
cell,	B-O
was	B-O
used	B-O
to	B-O
quantify	B-O
total	B-O
cellular	B-O
protein	B-O
by	B-O
automated	B-O
fluorescence	B-O
microscopy.	B-O
HDQ-P1	B-O
cells	B-O
were	B-O
exposed	B-O
to	B-O
G418,	B-O
Y-320,	B-O
or	B-O
their	B-O
combination	B-O
for	B-O
48	B-O
h	B-O
and	B-O
were	B-O
fixed	B-O
and	B-O
stained	B-O
with	B-O
SYPRO	B-O
Ruby	B-O
and	B-O
with	B-O
a	B-O
DNA	B-O
dye	B-O
to	B-O
identify	B-O
cells.	B-O
Compared	B-O
to	B-O
untreated	B-O
cells,	B-O
200	B-O
μM	B-O
G418	B-O
alone	B-O
did	B-O
not	B-O
significantly	B-O
affect	B-O
cellular	B-O
protein	B-O
levels	B-O
.	B-O
Unexpectedly,	B-O
Y-320	B-O
increased	B-O
cellular	B-O
protein	B-O
levels	B-O
in	B-O
a	B-O
concentration-dependent	B-O
manner,	B-O
reaching	B-O
2.9-fold	B-O
at	B-O
2	B-O
μM	B-O
.	B-O
The	B-O
combination	B-O
of	B-O
2	B-O
μM	B-O
Y-320	B-O
and	B-O
200	B-O
μM	B-O
G418	B-O
also	B-O
increased	B-O
cellular	B-O
protein,	B-O
to	B-O
a	B-O
slightly	B-O
lower	B-O
level	B-O
than	B-O
Y-320	B-O
alone	B-O
.	B-O
Download:	B-O
PPT	B-O
PowerPoint	B-O
slide	B-O
PNG	B-O
larger	B-O
image	B-O
TIFF	B-O
original	B-O
image	B-O
Fig	B-O
3.	B-O
Stimulation	B-O
of	B-O
protein	B-O
synthesis	B-O
by	B-O
Y-320	B-O
and	B-O
correlation	B-O
with	B-O
p53	B-O
readthrough	B-O
at	B-O
the	B-O
single	B-O
cell	B-O
level.	B-O
.	B-O
To	B-O
verify	B-O
that	B-O
the	B-O
effect	B-O
of	B-O
Y-320	B-O
on	B-O
protein	B-O
synthesis	B-O
was	B-O
not	B-O
exclusive	B-O
to	B-O
one	B-O
cell	B-O
line,	B-O
we	B-O
also	B-O
tested	B-O
protein	B-O
synthesis	B-O
in	B-O
H1299-R213X	B-O
cells	B-O
and	B-O
WT	B-AC
fibroblasts	B-O
treated	B-O
with	B-O
Y-320	B-O
alone	B-O
for	B-O
24	B-O
h.	B-O
Y-320	B-O
significantly	B-O
increased	B-O
protein	B-O
synthesis	B-O
in	B-O
both	B-O
cell	B-O
lines	B-O
.	B-O
These	B-O
results	B-O
indicate	B-O
that	B-O
Y-320	B-O
increases	B-O
protein	B-O
synthesis	B-O
activity	B-O
and	B-O
total	B-O
cellular	B-O
protein	B-O
levels.	B-O
The	B-O
enhancement	B-O
of	B-O
protein	B-O
synthesis	B-O
by	B-O
Y-320	B-O
could	B-O
reflect	B-O
higher	B-O
metabolic	B-O
demand	B-O
imposed	B-O
by	B-O
increased	B-O
cell	B-O
proliferation,	B-O
a	B-O
feature	B-O
seen	B-O
in	B-O
cancer	B-O
cells	B-O
[	B-O
24	B-O
,	B-O
25	B-O
].	B-O
To	B-O
test	B-O
this	B-O
possibility,	B-O
we	B-O
exposed	B-O
HDQ-P1	B-O
cells	B-O
to	B-O
Y-320	B-O
for	B-O
48	B-O
h	B-O
and	B-O
measured	B-O
cell	B-O
numbers.	B-O
Y-320	B-O
caused	B-O
a	B-O
10%	B-O
to	B-O
20%	B-O
reduction	B-O
in	B-O
cell	B-O
number	B-O
.	B-O
Additionally,	B-O
increasing	B-O
concentrations	B-O
of	B-O
Y-320	B-O
in	B-O
the	B-O
presence	B-O
of	B-O
G418	B-O
reduced	B-O
HDQ-P1	B-O
cell	B-O
viability	B-O
up	B-O
to	B-O
19%	B-O
and	B-O
35%	B-O
after	B-O
24	B-O
h	B-O
and	B-O
48	B-O
h,	B-O
respectively,	B-O
as	B-O
measured	B-O
using	B-O
the	B-O
.	B-O
Therefore,	B-O
enhanced	B-O
protein	B-O
synthesis	B-O
by	B-O
Y-320	B-O
was	B-O
not	B-O
a	B-O
consequence	B-O
of	B-O
increased	B-O
cell	B-O
proliferation.	B-O
We	B-O
reasoned	B-O
that	B-O
if	B-O
a	B-O
causal	B-O
relationship	B-O
exists	B-O
between	B-O
the	B-O
increased	B-O
protein	B-O
synthesis	B-O
brought	B-O
about	B-O
by	B-O
Y-320	B-O
and	B-O
its	B-O
readthrough	B-O
enhancement,	B-O
then	B-O
this	B-O
correlation	B-O
should	B-O
hold	B-O
at	B-O
the	B-O
single	B-O
cell	B-O
level.	B-O
In	B-O
other	B-O
words,	B-O
within	B-O
a	B-O
population	B-O
of	B-O
treated	B-O
cells,	B-O
individual	B-O
cells	B-O
showing	B-O
higher	B-O
PTC	B-AC
readthrough	B-O
should	B-O
also	B-O
show	B-O
higher	B-O
protein	B-O
synthesis.	B-O
We	B-O
carried	B-O
out	B-O
translation	B-O
elongation	B-O
experiments	B-O
in	B-O
which	B-O
HDQ-P1	B-O
cells	B-O
were	B-O
exposed	B-O
to	B-O
drugs	B-O
for	B-O
48	B-O
h,	B-O
at	B-O
which	B-O
point	B-O
harringtonine	B-O
was	B-O
added	B-O
to	B-O
block	B-O
translation	B-O
initiation,	B-O
together	B-O
with	B-O
puromycin	B-O
for	B-O
10	B-O
min.	B-O
The	B-O
cells	B-O
were	B-O
then	B-O
fixed,	B-O
labeled	B-O
with	B-O
anti-puromycin	B-O
and	B-O
anti-p53	B-O
antibodies,	B-O
and	B-O
the	B-O
immunofluorescence	B-O
signals	B-O
were	B-O
measured	B-O
in	B-O
approximately	B-O
2,000	B-O
individual	B-O
cells	B-O
per	B-O
treatment	B-O
using	B-O
automated	B-O
microscopy.	B-O
The	B-O
data	B-O
were	B-O
graphed	B-O
as	B-O
“lineup”	B-O
plots	B-O
with	B-O
the	B-O
cells	B-O
showing	B-O
lowest	B-O
to	B-O
highest	B-O
puromycin	B-O
incorporation	B-O
ranked	B-O
from	B-O
left	B-O
to	B-O
right	B-O
on	B-O
the	B-O
x	B-O
axis	B-O
and	B-O
corresponding	B-O
p53	B-O
levels	B-O
on	B-O
the	B-O
y	B-O
axis	B-O
.	B-O
Most	B-O
untreated	B-O
cells	B-O
displayed	B-O
similar	B-O
puromycin	B-O
incorporation,	B-O
with	B-O
a	B-O
minority	B-O
showing	B-O
a	B-O
distinctly	B-O
lower	B-O
or	B-O
higher	B-O
levels.	B-O
p53	B-O
levels	B-O
were	B-O
low	B-O
in	B-O
most	B-O
cells,	B-O
corresponding	B-O
to	B-O
background	B-O
immunofluorescence,	B-O
except	B-O
for	B-O
a	B-O
trend	B-O
toward	B-O
higher	B-O
p53	B-O
signal	B-O
in	B-O
cells	B-O
showing	B-O
higher	B-O
puromycin	B-O
incorporation	B-O
.	B-O
In	B-O
cells	B-O
exposed	B-O
to	B-O
G418	B-O
alone,	B-O
p53	B-O
levels	B-O
were	B-O
slightly	B-O
higher	B-O
in	B-O
many	B-O
cells	B-O
and	B-O
there	B-O
was	B-O
a	B-O
weak	B-O
positive	B-O
linear	B-O
correlation	B-O
between	B-O
p53	B-O
levels	B-O
and	B-O
translation	B-O
elongation	B-O
which	B-O
was	B-O
not	B-O
different	B-O
from	B-O
that	B-O
of	B-O
untreated	B-O
cells	B-O
.	B-O
Although	B-O
correlative,	B-O
these	B-O
results	B-O
are	B-O
consistent	B-O
with	B-O
a	B-O
causal	B-O
relationship	B-O
between	B-O
increased	B-O
protein	B-O
synthesis	B-O
and	B-O
increased	B-O
PTC	B-AC
readthrough.	B-O
Y-320	B-O
increases	B-O
ribosome	B-O
biogenesis	B-O
The	B-O
increased	B-O
translation	B-O
and	B-O
cellular	B-O
protein	B-O
levels	B-O
observed	B-O
in	B-O
cells	B-O
exposed	B-O
to	B-O
Y-320	B-O
might	B-O
reflect	B-O
a	B-O
higher	B-O
cellular	B-O
ribosomal	B-LF
content.	B-O
To	B-O
determine	B-O
whether	B-O
Y-320	B-O
enhanced	B-O
ribosome	B-O
biogenesis,	B-O
we	B-O
examined	B-O
the	B-O
expression	B-O
of	B-O
2	B-O
ribosomal	B-LF
markers,	B-O
the	B-O
S40	B-O
ribosomal	B-LF
subunit	B-O
protein	B-O
rpS6	B-O
and	B-O
ribosomal	B-LF
RNA	I-LF
.	B-O
However,	B-O
2	B-O
μM	B-O
Y-320	B-O
alone	B-O
and	B-O
combined	B-O
with	B-O
G418	B-O
increased	B-O
levels	B-O
of	B-O
rRNA	B-AC
.	B-O
At	B-O
24	B-O
h,	B-O
2	B-O
μM	B-O
Y-320	B-O
alone	B-O
also	B-O
increased	B-O
levels	B-O
of	B-O
rRNA	B-AC
Ribosome	B-O
biogenesis	B-O
in	B-O
HDQ-P1	B-O
cells.	B-O
HDQ-P1	B-O
cells	B-O
treated	B-O
with	B-O
the	B-O
indicated	B-O
compounds	B-O
for	B-O
24	B-O
h	B-O
and	B-O
48	B-O
h	B-O
were	B-O
fluorescently	B-O
labeled	B-O
using	B-O
antibodies	B-O
against	B-O
rRNA	B-AC
and	B-O
rpS6.	B-O
Asterisks	B-O
indicate	B-O
values	B-O
significantly	B-O
different	B-O
between	B-O
treated	B-O
and	B-O
untreated	B-O
cells	B-O
confirming	B-O
the	B-O
higher	B-O
levels	B-O
of	B-O
protein	B-O
synthesis	B-O
described	B-O
above.	B-O
Y-320	B-O
caused	B-O
a	B-O
small	B-O
steepening	B-O
of	B-O
the	B-O
negative	B-O
slope,	B-O
indicating	B-O
a	B-O
trend	B-O
toward	B-O
increased	B-O
translation	B-O
rate,	B-O
but	B-O
this	B-O
effect	B-O
was	B-O
not	B-O
statistically	B-O
significant,	B-O
indicating	B-O
Y-320	B-O
had	B-O
a	B-O
minimal	B-O
effect	B-O
on	B-O
the	B-O
translation	B-O
elongation	B-O
rate.	B-O
Additionally,	B-O
Y-320	B-O
did	B-O
not	B-O
affect	B-O
the	B-O
levels	B-O
of	B-O
eIF4G	B-O
or	B-O
the	B-O
phosphorylation	B-O
of	B-O
eIF4B	B-O
at	B-O
Ser	B-O
422,	B-O
two	B-O
proteins	B-O
involved	B-O
in	B-O
control	B-O
of	B-O
translation	B-O
initiation	B-O
.	B-O
Next,	B-O
we	B-O
explored	B-O
the	B-O
correlation	B-O
between	B-O
protein	B-O
synthesis	B-O
and	B-O
ribosome	B-O
biogenesis	B-O
at	B-O
the	B-O
single	B-O
cell	B-O
level	B-O
by	B-O
exposing	B-O
HDQ-P1	B-O
cells	B-O
to	B-O
drugs,	B-O
incubating	B-O
with	B-O
harringtonine	B-O
and	B-O
puromycin,	B-O
and	B-O
staining	B-O
the	B-O
cells	B-O
with	B-O
anti-puromycin	B-O
and	B-O
anti-rRNA	B-O
antibodies.	B-O
Exposure	B-O
to	B-O
Y-320	B-O
without	B-O
or	B-O
with	B-O
G418	B-O
increased	B-O
rRNA	B-AC
levels	B-O
in	B-O
the	B-O
vast	B-O
majority	B-O
of	B-O
cells	B-O
and	B-O
a	B-O
positive	B-O
correlation	B-O
between	B-O
rRNA	B-AC
levels	B-O
and	B-O
translation	B-O
elongation	B-O
was	B-O
observed	B-O
.	B-O
Upon	B-O
exposure	B-O
to	B-O
the	B-O
combination	B-O
of	B-O
Y-320	B-O
and	B-O
G418,	B-O
a	B-O
strong	B-O
positive	B-O
correlation	B-O
was	B-O
observed	B-O
between	B-O
higher	B-O
levels	B-O
of	B-O
rRNA	B-AC
and	B-O
higher	B-O
p53	B-O
levels	B-O
signaling,	B-O
a	B-O
pathway	B-O
known	B-O
to	B-O
control	B-O
protein	B-O
synthesis	B-O
and	B-O
ribosome	B-O
biogenesis	B-O
[	B-O
26	B-O
,	B-O
27	B-O
].	B-O
The	B-O
tuberous	B-O
sclerosis	B-O
complex	B-O
genes	B-O
TSC1	B-O
and	B-O
TSC2	B-O
are	B-O
negative	B-O
regulators	B-O
of	B-O
mTOR	B-AC
signaling	B-O
.	B-O
We	B-O
examined	B-O
the	B-O
effect	B-O
of	B-O
Y-320	B-O
on	B-O
cellular	B-O
protein	B-O
and	B-O
ribosomal	B-LF
RNA	I-LF
in	B-O
immortalized	B-O
Tsc2	B-O
−/−	B-O
mouse	B-O
embryo	B-O
fibroblasts,	B-O
which	B-O
feature	B-O
constitutively	B-O
high	B-O
mTOR	B-AC
activity	B-O
[	B-O
28	B-O
,	B-O
29	B-O
].	B-O
Tsc2	B-O
−/−	B-O
cells	B-O
were	B-O
exposed	B-O
to	B-O
Y-320	B-O
without	B-O
or	B-O
with	B-O
G418	B-O
for	B-O
48	B-O
h,	B-O
fixed	B-O
and	B-O
probed	B-O
with	B-O
SYPRO	B-O
Ruby	B-O
stain	B-O
and	B-O
anti-rRNA	B-O
antibody.	B-O
Y-320	B-O
increased	B-O
levels	B-O
of	B-O
cellular	B-O
protein	B-O
and	B-O
rRNA	B-AC
up	B-O
to	B-O
4.3-fold	B-O
and	B-O
3.6-fold,	B-O
respectively,	B-O
compared	B-O
to	B-O
controls	B-O
.	B-O
Activation	B-O
of	B-O
mTOR	B-AC
signaling	B-O
leads	B-O
to	B-O
phosphorylation	B-O
of	B-O
downstream	B-O
proteins	B-O
ribosomal	B-LF
S6	B-LF
kinase	I-LF
.	B-O
These	B-O
results	B-O
indicate	B-O
that	B-O
Y-320	B-O
can	B-O
increase	B-O
cellular	B-O
protein	B-O
levels	B-O
and	B-O
ribosome	B-O
biogenesis	B-O
even	B-O
in	B-O
the	B-O
presence	B-O
of	B-O
highly	B-O
active	B-O
mTOR	B-AC
signaling.	B-O
Download:	B-O
PPT	B-O
PowerPoint	B-O
slide	B-O
PNG	B-O
larger	B-O
image	B-O
TIFF	B-O
original	B-O
image	B-O
Fig	B-O
5.	B-O
Y-320	B-O
stimulates	B-O
protein	B-O
synthesis	B-O
independently	B-O
of	B-O
mTOR	B-AC
signaling.	B-O
,	B-O
as	B-O
previously	B-O
reported	B-O
in	B-O
other	B-O
cell	B-O
lines	B-O
[	B-O
26	B-O
,	B-O
32	B-O
].	B-O
Next,	B-O
we	B-O
exposed	B-O
HDQ-P1	B-O
cells	B-O
to	B-O
Y-320	B-O
without	B-O
or	B-O
with	B-O
G418,	B-O
together	B-O
with	B-O
different	B-O
concentrations	B-O
of	B-O
rapamycin	B-O
for	B-O
48	B-O
h,	B-O
fixed	B-O
and	B-O
stained	B-O
them	B-O
with	B-O
SYPRO	B-O
Ruby	B-O
or	B-O
fluorescently	B-O
labeled	B-O
them	B-O
using	B-O
the	B-O
antibodies	B-O
against	B-O
rRNA	B-AC
and	B-O
p53.	B-O
We	B-O
observed	B-O
that	B-O
rapamycin	B-O
by	B-O
itself	B-O
did	B-O
not	B-O
affect	B-O
the	B-O
overall	B-O
protein	B-O
levels,	B-O
as	B-O
previously	B-O
described	B-O
nor	B-O
did	B-O
it	B-O
inhibit	B-O
the	B-O
effects	B-O
of	B-O
Y-320	B-O
on	B-O
cellular	B-O
protein,	B-O
rRNA,	B-O
or	B-O
p53	B-O
levels	B-O
,	B-O
except	B-O
for	B-O
a	B-O
minor	B-O
reduction	B-O
in	B-O
SYPRO	B-O
Ruby	B-O
staining	B-O
at	B-O
10	B-O
nM	B-O
rapamycin.	B-O
These	B-O
results	B-O
indicate	B-O
that	B-O
inhibition	B-O
of	B-O
mTOR	B-AC
signaling	B-O
is	B-O
not	B-O
sufficient	B-O
to	B-O
prevent	B-O
Y-320	B-O
from	B-O
increasing	B-O
protein	B-O
levels,	B-O
ribosome	B-O
biogenesis,	B-O
or	B-O
PTC	B-AC
readthrough	B-O
and	B-O
that	B-O
the	B-O
effects	B-O
of	B-O
Y-320	B-O
are	B-O
not	B-O
mediated	I-LF
by	B-O
mTOR	B-AC
signaling.	B-O
Effect	B-O
of	B-O
Y-320	B-O
on	B-O
translation	B-O
fidelity	B-O
Given	B-O
the	B-O
surprising	B-O
result	B-O
that	B-O
Y-320	B-O
increased	B-O
cellular	B-O
protein	B-O
synthesis,	B-O
we	B-O
wondered	B-O
to	B-O
what	B-O
extent	B-O
this	B-O
process	B-O
might	B-O
be	B-O
dysfunctional.	B-O
We	B-O
assessed	B-O
translation	B-O
fidelity	B-O
during	B-O
Y-320	B-O
treatment	B-O
using	B-O
a	B-O
set	B-O
of	B-O
firefly	B-O
luciferase	B-O
mutant	B-O
reporters	B-O
in	B-O
H1299	B-O
cells	B-O
.	B-O
In	B-O
these	B-O
reporters,	B-O
lysine	B-O
529	B-O
is	B-O
mutated,	B-O
leading	B-O
to	B-O
defective	B-O
luciferase	B-O
activity,	B-O
and	B-O
misincorporation	B-O
of	B-O
lysine	B-O
at	B-O
the	B-O
mutated	B-O
site	B-O
results	B-O
in	B-O
restoration	B-O
of	B-O
luciferase	B-O
activity.	B-O
The	B-O
mutations	B-O
consisted	B-O
of	B-O
nucleotide	B-O
substitution	B-O
at	B-O
the	B-O
first	B-O
.	B-O
G418	B-O
alone	B-O
had	B-O
no	B-O
effect	B-O
on	B-O
the	B-O
frameshift	B-O
mutations	B-O
or	B-O
on	B-O
missense	B-O
mutations	B-O
K529E	B-O
and	B-O
K529I	B-O
but	B-O
it	B-O
increased	B-O
amino	B-O
acid	B-O
misincorporation	B-O
at	B-O
K529N	B-O
and	B-O
it	B-O
induced	B-O
readthrough	B-O
at	B-O
the	B-O
PTC.	B-O
Y-320	B-O
alone	B-O
had	B-O
no	B-O
effect	B-O
on	B-O
any	B-O
of	B-O
the	B-O
mutants,	B-O
indicating	B-O
no	B-O
observable	B-O
effect	B-O
on	B-O
translation	B-O
fidelity.	B-O
The	B-O
combination	B-O
of	B-O
G418	B-O
and	B-O
Y-320	B-O
had	B-O
no	B-O
observable	B-O
effect	B-O
on	B-O
missense	B-O
mutations	B-O
K529E,	B-O
K529I,	B-O
or	B-O
the	B-O
frameshift	B-O
mutants.	B-O
However,	B-O
the	B-O
combination	B-O
of	B-O
Y-320	B-O
and	B-O
G418	B-O
increased	B-O
PTC	B-AC
readthrough	B-O
by	B-O
G418,	B-O
as	B-O
expected,	B-O
and	B-O
it	B-O
also	B-O
increased	B-O
misincorporation	B-O
at	B-O
K529N	B-O
compared	B-O
to	B-O
G418	B-O
alone	B-O
.	B-O
The	B-O
positive	B-O
control	B-O
.	B-O
Considering	B-O
that	B-O
3	B-O
chemokines	B-O
were	B-O
among	B-O
the	B-O
5	B-O
most	B-O
up-regulated	B-O
genes	B-O
and	B-O
the	B-O
previously	B-O
reported	B-O
immunomodulatory	B-O
activity	B-O
of	B-O
Y-320	B-O
,	B-O
we	B-O
decided	B-O
to	B-O
focus	B-O
on	B-O
these	B-O
genes.	B-O
CXC	B-O
chemokine	B-O
ligands	B-O
CXCL10,	B-O
CXCL8,	B-O
and	B-O
CXCL2	B-O
showed	B-O
log	B-O
2	B-O
fold	B-O
increase	B-O
>3,	B-O
and	B-O
CXCL11	B-O
and	B-O
CXCL3	B-O
showed	B-O
log	B-O
2	B-O
fold	B-O
increase	B-O
>2	B-O
.	B-O
CXCL1	B-O
and	B-O
CXCL16	B-O
were	B-O
also	B-O
up-regulated	B-O
by	B-O
Y-320	B-O
although	B-O
to	B-O
a	B-O
lesser	B-O
degree	B-O
.	B-O
CXC	B-O
chemokines	B-O
are	B-O
small	B-O
secreted	B-O
proteins	B-O
that	B-O
have	B-O
been	B-O
attributed	B-O
several	B-O
roles	B-O
including	B-O
chemotaxis	B-O
in	B-O
cells	B-O
expressing	B-O
receptors	B-O
for	B-O
these	B-O
chemokines	B-O
.	B-O
CXCL10,	B-O
CXCL8,	B-O
CXCL2,	B-O
and	B-O
CXCL3	B-O
can	B-O
also	B-O
induce	B-O
cell	B-O
growth	B-O
and	B-O
proliferation	B-O
and	B-O
are	B-O
putative	B-O
autocrine	B-O
or	B-O
paracrine	B-O
growth	B-O
factors	B-O
in	B-O
cancer	B-O
[	B-O
36	B-O
–	B-O
38	B-O
].	B-O
CXCL8,	B-O
CXCL2,	B-O
CXCL3,	B-O
and	B-O
CXCL1	B-O
act	B-O
through	B-O
a	B-O
common	B-O
receptor,	B-O
CXCR2	B-O
,	B-O
which	B-O
showed	B-O
no	B-O
up-regulation	B-O
in	B-O
our	B-O
RNA-seq	B-AC
data.	B-O
Download:	B-O
PPT	B-O
PowerPoint	B-O
slide	B-O
PNG	B-O
larger	B-O
image	B-O
TIFF	B-O
original	B-O
image	B-O
Fig	B-O
7.	B-O
Up-regulation	B-O
of	B-O
CXC	B-O
chemokines	B-O
by	B-O
Y-320	B-O
and	B-O
effect	B-O
of	B-O
SB225002	B-O
on	B-O
protein	B-O
levels	B-O
and	B-O
PTC	B-AC
readthrough.	B-O
.	B-O
The	B-O
increase	B-O
in	B-O
cellular	B-O
protein	B-O
levels	B-O
elicited	B-O
by	B-O
Y-320	B-O
alone	B-O
and	B-O
Y-320	B-O
combined	B-O
with	B-O
G418	B-O
was	B-O
reduced	B-O
by	B-O
SB225002	B-O
in	B-O
a	B-O
concentration-dependent	B-O
manner	B-O
.	B-O
SB225002	B-O
also	B-O
considerably	B-O
decreased	B-O
in	B-O
a	B-O
concentration-dependent	B-O
manner	B-O
PTC	B-AC
readthrough	B-O
elicited	B-O
by	B-O
the	B-O
combination	B-O
of	B-O
G418	B-O
and	B-O
Y-320,	B-O
both	B-O
in	B-O
the	B-O
immunofluorescence	B-O
assay	B-O
and	B-O
by	B-O
western	B-O
analysis	B-O
.	B-O
These	B-O
results	B-O
indicate	B-O
that	B-O
the	B-O
effects	B-O
of	B-O
Y-320	B-O
on	B-O
increased	B-O
protein	B-O
synthesis	B-O
and	B-O
PTC	B-AC
readthrough	B-O
are	B-O
mediated	I-LF
in	B-O
large	B-O
part	B-O
by	B-O
an	B-O
autocrine	B-O
mechanism	B-O
involving	B-O
up-regulation	B-O
of	B-O
chemokine	B-O
expression	B-O
and	B-O
secretion	B-O
and	B-O
increased	B-O
signaling	B-O
through	B-O
a	B-O
chemokine	B-O
receptor.	B-O
Discussion	B-O
Aminoglycosides	B-O
suffer	B-O
several	B-O
limitations	B-O
as	B-O
potential	B-O
PTC	B-AC
readthrough	B-O
treatments	B-O
for	B-O
rare	B-O
genetic	B-O
disorders.	B-O
At	B-O
the	B-O
organismal	B-O
level,	B-O
they	B-O
are	B-O
known	B-O
to	B-O
cause	B-O
oto-	B-O
and	B-O
nephro-toxicity	B-O
via	B-O
preferential	B-O
accumulation	B-O
and	B-O
retention	B-O
in	B-O
cochlear	B-O
cells	B-O
and	B-O
proximal	B-O
tubule	B-O
cells	B-O
[	B-O
42	B-O
–	B-O
44	B-O
].	B-O
At	B-O
the	B-O
cellular	B-O
level,	B-O
their	B-O
toxicity	B-O
has	B-O
been	B-O
linked	B-O
to	B-O
damage	B-O
to	B-O
the	B-O
lysosomal	B-O
membrane	B-O
following	B-O
uptake	B-O
by	B-O
endocytosis	B-O
and	B-O
accumulation	B-O
in	B-O
this	B-O
compartment	B-O
[	B-O
45	B-O
–	B-O
47	B-O
],	B-O
as	B-O
well	B-O
as	B-O
inhibition	B-O
of	B-O
mitochondrial	B-O
protein	B-O
synthesis	B-O
[	B-O
12	B-O
,	B-O
15	B-O
].	B-O
Here,	B-O
we	B-O
illustrate	B-O
a	B-O
further	B-O
limitation:	B-O
inhibition	B-O
of	B-O
cytosolic	B-O
protein	B-O
synthesis	B-O
at	B-O
the	B-O
G418	B-O
concentrations	B-O
that	B-O
are	B-O
required	B-O
for	B-O
readthrough.	B-O
As	B-O
a	B-O
result,	B-O
the	B-O
maximum	B-O
levels	B-O
of	B-O
PTC	B-AC
readthrough	B-O
achievable	B-O
by	B-O
G418	B-O
are	B-O
low,	B-O
even	B-O
in	B-O
a	B-O
cell-free	B-O
translation	B-O
assay,	B-O
where	B-O
the	B-O
other	B-O
factors	B-O
described	B-O
above	B-O
are	B-O
not	B-O
at	B-O
play.	B-O
Whether	B-O
inhibition	B-O
of	B-O
protein	B-O
synthesis	B-O
at	B-O
concentrations	B-O
that	B-O
induce	B-O
readthrough	B-O
is	B-O
due	B-O
to	B-O
higher	B-O
occupancy	B-O
of	B-O
the	B-O
decoding	B-O
center	B-O
or	B-O
to	B-O
binding	B-O
to	B-O
additional	B-O
sites	B-O
on	B-O
the	B-O
ribosome	B-O
remains	B-O
to	B-O
be	B-O
deteremined.	B-O
It	B-O
will	B-O
likely	B-O
be	B-O
important	B-O
to	B-O
also	B-O
consider	B-O
this	B-O
self-limiting	B-O
process	B-O
when	B-O
developing	B-O
improved	B-O
aminoglycosides	B-O
for	B-O
readthrough	B-O
therapy.	B-O
Here,	B-O
we	B-O
asked	B-O
whether	B-O
PTC	B-AC
readthrough	B-O
could	B-O
be	B-O
increased	B-O
without	B-O
further	B-O
inhibiting	B-O
protein	B-O
synthesis	B-O
by	B-O
combining	B-O
G418	B-O
with	B-O
another	B-O
small	B-O
molecule.	B-O
We	B-O
first	B-O
identified	B-O
Y-320	B-O
as	B-O
a	B-O
potent	B-O
enhancer	B-O
of	B-O
G418-induced	B-O
PTC	B-AC
readthrough	B-O
active	B-O
against	B-O
nonsense	B-LF
mutations	B-O
in	B-O
different	B-O
genes	B-O
and	B-O
patient-derived	B-O
cells	B-O
of	B-O
different	B-O
tissue	B-O
origins.	B-O
When	B-O
used	B-O
alone,	B-O
Y-320	B-O
did	B-O
not	B-O
increase	B-O
R213X	B-O
TP53	B-O
mRNA	B-O
levels,	B-O
indicating	B-O
it	B-O
is	B-O
not	B-O
an	B-O
NMD	B-AC
inhibitor.	B-O
The	B-O
combination	B-O
of	B-O
Y-320	B-O
and	B-O
G418	B-O
increased	B-O
R213X	B-O
TP53	B-O
mRNA	B-O
to	B-O
a	B-O
higher	B-O
level	B-O
than	B-O
G418	B-O
alone,	B-O
which	B-O
is	B-O
likely	B-O
a	B-O
consequence	B-O
of	B-O
increased	B-O
readthrough	B-O
by	B-O
the	B-O
combination,	B-O
as	B-O
is	B-O
the	B-O
higher	B-O
level	B-O
of	B-O
truncated	B-O
p53	B-O
[	B-O
9	B-O
,	B-O
16	B-O
].	B-O
In	B-O
the	B-O
particular	B-O
case	B-O
of	B-O
p53,	B-O
which	B-O
acts	B-O
as	B-O
a	B-O
tetramer,	B-O
the	B-O
presence	B-O
of	B-O
truncated	B-O
p53	B-O
has	B-O
potential	B-O
to	B-O
inhibit	B-O
p53	B-O
function	B-O
by	B-O
a	B-O
dominant-negative	B-O
mechanism	B-O
[	B-O
48	B-O
,	B-O
49	B-O
].	B-O
The	B-O
levels	B-O
of	B-O
full-length	B-O
products	B-O
induced	B-O
by	B-O
readthrough	B-O
in	B-O
DMD	B-AC
and	B-O
JEB	B-AC
cells	B-O
were	B-O
very	B-O
low	B-O
compared	B-O
to	B-O
those	B-O
of	B-O
WT	B-AC
myoblasts	B-O
and	B-O
keratinocytes.	B-O
However,	B-O
considering	B-O
the	B-O
long	B-O
half-lives	B-O
.	B-O
Moreover,	B-O
cells	B-O
exposed	B-O
to	B-O
Y-320	B-O
showed	B-O
higher	B-O
levels	B-O
of	B-O
ribosomal	B-LF
markers	B-O
rRNA	B-AC
and	B-O
ribosomal	B-LF
protein	B-O
S6,	B-O
consistent	B-O
with	B-O
stimulation	B-O
of	B-O
ribosome	B-O
biogenesis	B-O
underlying	B-O
the	B-O
increased	B-O
cellular	B-O
protein	B-O
levels	B-O
and	B-O
synthesis.	B-O
It	B-O
is	B-O
noteworthy	B-O
that	B-O
CDX5-288	B-O
and	B-O
CDX6-180,	B-O
two	B-O
structurally	B-O
distinct	B-O
readthrough	B-O
enhancers	B-O
recently	B-O
identified	B-O
in	B-O
our	B-O
laboratory,	B-O
showed	B-O
no	B-O
stimulation	B-O
of	B-O
ribosome	B-O
biogenesis	B-O
.	B-O
To	B-O
our	B-O
knowledge,	B-O
increased	B-O
protein	B-O
synthesis	B-O
activity	B-O
has	B-O
not	B-O
previously	B-O
been	B-O
linked	B-O
to	B-O
enhancement	B-O
of	B-O
PTC	B-AC
readthrough	B-O
by	B-O
an	B-O
aminoglycoside.	B-O
We	B-O
were	B-O
interested	B-O
to	B-O
determine	B-O
whether	B-O
a	B-O
causal	B-O
relationship	B-O
existed	B-O
between	B-O
these	B-O
2	B-O
processes.	B-O
This	B-O
is	B-O
not	B-O
an	B-O
easy	B-O
question	B-O
to	B-O
address	B-O
as	B-O
protein	B-O
synthesis	B-O
is	B-O
fundamentally	B-O
linked	B-O
to	B-O
essentially	B-O
all	B-O
cellular	B-O
activities,	B-O
and	B-O
it	B-O
is	B-O
not	B-O
suited	B-O
to	B-O
gene	B-O
down-regulation	B-O
or	B-O
overexpression	B-O
approaches	B-O
often	B-O
used	B-O
to	B-O
validate	B-O
drug	B-O
targets.	B-O
We	B-O
first	B-O
elected	B-O
to	B-O
verify	B-O
whether	B-O
the	B-O
correlation	B-O
observed	B-O
between	B-O
increased	B-O
protein	B-O
synthesis,	B-O
increased	B-O
ribosomal	B-LF
markers,	B-O
and	B-O
increased	B-O
PTC	B-AC
readthrough	B-O
observed	B-O
at	B-O
the	B-O
cell	B-O
population	B-O
level	B-O
also	B-O
held	B-O
at	B-O
the	B-O
cellular	B-O
level,	B-O
reasoning	B-O
that	B-O
a	B-O
lack	B-O
of	B-O
association	B-O
at	B-O
the	B-O
individual	B-O
cell	B-O
level	B-O
would	B-O
indicate	B-O
unrelated	B-O
effects.	B-O
A	B-O
strong	B-O
correlation	B-O
was	B-O
observed	B-O
between	B-O
increased	B-O
rRNA	B-AC
levels	B-O
and	B-O
puromycin	B-O
incorporation,	B-O
which	B-O
was	B-O
not	B-O
surprising	B-O
and	B-O
indicated	B-O
the	B-O
additional	B-O
ribosomes	B-O
produced	B-O
during	B-O
incubation	B-O
with	B-O
Y-320	B-O
were	B-O
functional.	B-O
In	B-O
individual	B-O
cells	B-O
exposed	B-O
to	B-O
G418	B-O
and	B-O
2	B-O
μM	B-O
Y-320,	B-O
we	B-O
also	B-O
observed	B-O
strong	B-O
positive	B-O
correlations	B-O
between	B-O
puromycin	B-O
incorporation	B-O
and	B-O
PTC	B-AC
readthrough	B-O
,	B-O
where	B-O
misreading	B-O
most	B-O
often	B-O
occurs	B-O
because	B-O
interaction	B-O
at	B-O
the	B-O
cognate	B-O
base	B-O
is	B-O
weaker	B-O
than	B-O
at	B-O
the	B-O
first	B-O
and	B-O
second	B-O
positions	B-O
[	B-O
50	B-O
,	B-O
51	B-O
].	B-O
Y-320	B-O
was	B-O
discovered	B-O
in	B-O
a	B-O
phenotypic	B-O
cell-based	B-O
screen	B-O
as	B-O
a	B-O
compound	B-O
that	B-O
inhibited	B-O
IL-17	B-O
production	B-O
by	B-O
murine	B-O
CD4	B-O
T	B-O
cells	B-O
stimulated	B-O
with	B-O
a	B-O
cocktail	B-O
of	B-O
IL-15,	B-O
CXCL12,	B-O
and	B-O
anti-CD3	B-O
mAb	B-AC
[	B-O
20	B-O
,	B-O
34	B-O
].	B-O
Y-320	B-O
also	B-O
ameliorated	B-O
type	B-O
II	B-O
collagen-induced	B-O
arthritis	B-O
in	B-O
mice	B-O
and	B-O
monkeys	B-O
and	B-O
reduced	B-O
IL-17	B-O
mRNA	B-O
expression	B-O
in	B-O
arthritic	B-O
joints	B-O
in	B-O
mice	B-O
.	B-O
However,	B-O
a	B-O
direct	B-O
target	B-O
for	B-O
Y-320	B-O
and	B-O
its	B-O
cellular	B-O
mechanism	B-O
of	B-O
action	B-O
have	B-O
not	B-O
been	B-O
described.	B-O
A	B-O
recent	B-O
study	B-O
has	B-O
shown	B-O
that	B-O
Y-320	B-O
can	B-O
also	B-O
inhibit	B-O
the	B-O
P-glycoprotein	B-O
efflux	B-O
pump	B-O
and	B-O
sensitize	B-O
multidrug	B-O
resistant	B-O
tumors	B-O
to	B-O
chemotherapy	B-O
.	B-O
We	B-O
examined	B-O
whether	B-O
the	B-O
effect	B-O
of	B-O
Y-320	B-O
was	B-O
dependent	B-O
on	B-O
mTOR,	B-O
a	B-O
major	B-O
regulator	B-O
of	B-O
protein	B-O
synthesis	B-O
and	B-O
ribosome	B-O
biogenesis.	B-O
Experiments	B-O
with	B-O
Tsc2	B-O
−/−	B-O
cells	B-O
expressing	B-O
high	B-O
levels	B-O
of	B-O
mTOR	B-AC
activity	B-O
and	B-O
with	B-O
the	B-O
mTOR	B-AC
inhibitor	B-O
rapamycin	B-O
indicated	B-O
no	B-O
involvement	B-O
of	B-O
mTOR.	B-O
To	B-O
further	B-O
probe	B-O
the	B-O
mechanism	B-O
of	B-O
action	B-O
of	B-O
Y-320,	B-O
we	B-O
determined	B-O
its	B-O
effects	B-O
on	B-O
gene	B-O
expression	B-O
in	B-O
HDQ-P1	B-O
cells.	B-O
Our	B-O
RNA-seq	B-AC
data	B-O
showed	B-O
Y-320	B-O
strongly	B-O
up-regulated	B-O
the	B-O
expression	B-O
of	B-O
chemokines	B-O
CXCL10,	B-O
CXCL8,	B-O
CXCL2,	B-O
CXCL11,	B-O
and	B-O
CXCL3,	B-O
and	B-O
moderately	B-O
up-regulated	B-O
CXCL1	B-O
and	B-O
CXCL16.	B-O
Chemokines	B-O
and	B-O
their	B-O
receptors	B-O
are	B-O
produced	B-O
by	B-O
many	B-O
cells	B-O
including	B-O
fibroblasts,	B-O
immune	B-O
cells,	B-O
and	B-O
cancer	B-O
cells.	B-O
Chemokines	B-O
have	B-O
well	B-O
established	B-O
roles	B-O
in	B-O
homeostasis	B-O
and	B-O
controlling	B-O
cell	B-O
migration	B-O
during	B-O
organ	B-O
development	B-O
as	B-O
well	B-O
as	B-O
leukocyte	B-O
activation	B-O
and	B-O
trafficking	B-O
during	B-O
immune	B-O
responses	B-O
[	B-O
35	B-O
,	B-O
53	B-O
,	B-O
54	B-O
].	B-O
Chemokines	B-O
also	B-O
play	B-O
roles	B-O
in	B-O
the	B-O
biology	B-O
of	B-O
nonimmune	B-O
cells.	B-O
Chemokines	B-O
expressed	B-O
by	B-O
cancer	B-O
cells	B-O
and	B-O
stromal	B-O
cells	B-O
can	B-O
stimulate	B-O
tumor	B-O
growth,	B-O
progression	B-O
and	B-O
metastasis	B-O
[	B-O
35	B-O
,	B-O
55	B-O
,	B-O
56	B-O
],	B-O
and	B-O
chemokines	B-O
have	B-O
been	B-O
described	B-O
as	B-O
putative	B-O
autocrine	B-O
or	B-O
paracrine	B-O
growth	B-O
factors	B-O
in	B-O
cancer	B-O
[	B-O
36	B-O
–	B-O
38	B-O
].	B-O
To	B-O
our	B-O
knowledge,	B-O
the	B-O
effect	B-O
of	B-O
CXCL	B-O
chemokines	B-O
on	B-O
ribosome	B-O
biogenesis	B-O
and	B-O
protein	B-O
synthesis	B-O
has	B-O
not	B-O
been	B-O
investigated,	B-O
but	B-O
proinflammatory	B-O
cytokines	B-O
have	B-O
previously	B-O
been	B-O
shown	B-O
to	B-O
increase	B-O
the	B-O
global	B-O
translation	B-O
rate	B-O
in	B-O
bronchial	B-O
epithelial	B-O
cells	B-O
.	B-O
CXCL8,	B-O
CXCL2,	B-O
CXCL3,	B-O
and	B-O
CXCL1	B-O
exert	B-O
their	B-O
effects	B-O
through	B-O
the	B-O
receptor	B-O
CXCR2	B-O
.	B-O
Here,	B-O
the	B-O
CXCR2	B-O
antagonist	B-O
SB225002	B-O
reduced	B-O
the	B-O
increase	B-O
in	B-O
protein	B-O
levels	B-O
and	B-O
PTC	B-AC
readthrough	B-O
caused	B-O
by	B-O
Y-320	B-O
and	B-O
G418	B-O
while	B-O
having	B-O
no	B-O
effect	B-O
on	B-O
basal	B-O
protein	B-O
synthesis	B-O
in	B-O
cells	B-O
not	B-O
exposed	B-O
to	B-O
the	B-O
readthrough	B-O
compounds.	B-O
This	B-O
key	B-O
experiment	B-O
suggests	B-O
a	B-O
model	B-O
whereby	B-O
Y-320,	B-O
at	B-O
least	B-O
in	B-O
part,	B-O
exerted	B-O
these	B-O
effects	B-O
in	B-O
an	B-O
autocrine	B-O
manner	B-O
through	B-O
up-regulating	B-O
the	B-O
expression	B-O
and	B-O
secretion	B-O
of	B-O
chemokines	B-O
that	B-O
then	B-O
bound	B-O
to	B-O
cell	B-O
surface	B-O
CXCR2	B-O
to	B-O
induce	B-O
an	B-O
intracellular	B-O
signal	B-O
that	B-O
increased	B-O
protein	B-O
synthesis	B-O
and	B-O
PTC	B-AC
readthrough.	B-O
One	B-O
implication	B-O
of	B-O
this	B-O
mechanism	B-O
is	B-O
that	B-O
pro-inflammatory	B-O
signals	B-O
might	B-O
generally	B-O
enhance	B-O
PTC	B-AC
readthrough	B-O
by	B-O
an	B-O
aminoglycoside.	B-O
This	B-O
may	B-O
be	B-O
relevant	B-O
to	B-O
the	B-O
treatment	B-O
of	B-O
recessive	B-LF
dystrophic	I-LF
EB	I-LF
and	B-O
R213X	B-O
TP53	B-O
S3	B-O
Fig.	B-O
Y-320	B-O
does	B-O
not	B-O
increase	B-O
COL17A1	B-O
levels	B-O
in	B-O
HaCat	B-O
cells.	B-O
HaCat	B-O
cells	B-O
were	B-O
exposed	B-O
to	B-O
the	B-O
indicated	B-O
compounds	B-O
for	B-O
72	B-O
h.	B-O
Cells	B-O
were	B-O
lysed	B-O
and	B-O
equal	B-O
amounts	B-O
of	B-O
protein	B-O
were	B-O
subjected	B-O
to	B-O
automated	B-O
capillary	B-O
electrophoresis	B-O
western	B-O
analysis.	B-O
Shown	B-O
are	B-O
pseudo	B-O
blots	B-O
of	B-O
chemiluminescence	B-O
of	B-O
bound	B-O
COL17A1	B-O
and	B-O
beta-actin	B-O
antibodies.	B-O
The	B-O
area	B-O
under	B-O
the	B-O
full-length	B-O
COL17A1	B-O
peaks	B-O
was	B-O
first	B-O
normalized	B-O
to	B-O
the	B-O
beta-actin	B-O
loading	B-O
control	B-O
and	B-O
then	B-O
divided	B-O
to	B-O
that	B-O
of	B-O
30	B-O
μM	B-O
G418	B-O
to	B-O
provide	B-O
lane-to-lane	B-O
comparison.	B-O
These	B-O
numbers	B-O
are	B-O
displayed	B-O
under	B-O
the	B-O
lanes.	B-O
Uncropped	B-O
images	B-O
of	B-O
automated	B-O
capillary	B-O
electrophoresis	B-O
western	B-O
analysis	B-O
are	B-O
provided	B-O
in	B-O
S1	B-O
Raw	B-O
Images	B-O
.	B-O
and	B-O
full-length	B-O
p53	B-O
chemiluminescence	B-O
is	B-O
expressed	B-O
relative	B-O
to	B-O
the	B-O
maximum	B-O
value	B-O
and	B-O
shown	B-O
under	B-O
each	B-O
lane.	B-O
Uncropped	B-O
images	B-O
of	B-O
automated	B-O
capillary	B-O
electrophoresis	B-O
western	B-O
analysis	B-O
are	B-O
provided	B-O
in	B-O
S1	B-O
Raw	B-O
Images	B-O
.	B-O
Detection	B-O
of	B-O
protein	B-O
synthesis	B-O
in	B-O
WT	B-AC
fibroblasts.	B-O
Fibroblasts	B-O
treated	B-O
with	B-O
Y-320	B-O
for	B-O
24	B-O
h	B-O
were	B-O
exposed	B-O
to	B-O
HPG	B-AC
reagent,	B-O
fluorescently	B-O
labeled	B-O
using	B-O
Alexa	B-O
Fluor	B-O
488	B-O
azide	B-O
and	B-O
imaged	B-O
using	B-O
automated	B-O
immunofluorescence	B-O
microscopy.	B-O
.	B-O
The	B-O
numerical	B-O
data	B-O
underlying	B-O
the	B-O
plot	B-O
can	B-O
be	B-O
found	B-O
in	B-O
S6	B-LF
Data	B-O
.	B-O
or	B-O
48	B-O
h	B-O
for	B-O
different	B-O
times	B-O
and	B-O
H1299-R213X	B-O
.	B-O
The	B-O
numerical	B-O
data	B-O
underlying	B-O
the	B-O
plot	B-O
can	B-O
be	B-O
found	B-O
in	B-O
S6	B-LF
Data	B-O
.	B-O
,	B-O
anti-rRNA	B-O
S2	B-O
Data.	B-O
Numerical	B-O
raw	B-O
data.	B-O
All	B-O
numerical	B-O
raw	B-O
data	B-O
associated	B-O
with	B-O
Fig	B-O
4A–4C	B-O
.	B-O
File	B-O
contains	B-O
multiple	B-O
tabs	B-O
with	B-O
labels	B-O
corresponding	B-O
to	B-O
the	B-O
relevant	B-O
figure.	B-O
S4	B-O
Data.	B-O
Numerical	B-O
raw	B-O
data.	B-O
All	B-O
numerical	B-O
raw	B-O
data	B-O
associated	B-O
with	B-O
Fig	B-O
6	B-O
.	B-O
S6	B-LF
Data.	B-O
Numerical	B-O
raw	B-O
data.	B-O
All	B-O
numerical	B-O
raw	B-O
data	B-O
associated	B-O
with	B-O
S1A,	B-O
S1B	B-O
,	B-O
S4A	B-O
,	B-O
S4B	B-O
,	B-O
S6A	B-O
,	B-O
S6B	B-O
,	B-O
S7	B-O
,	B-O
S8A	B-O
,	B-O
S8B	B-O
,	B-O
S9	B-O
,	B-O
S11	B-O
and	B-O
S12A–S12C	B-O
Figs.	B-O
File	B-O
contains	B-O
multiple	B-O
tabs	B-O
with	B-O
labels	B-O
corresponding	B-O
to	B-O
the	B-O
relevant	B-O
figure.	B-O
(XLSX)	B-O
S1	B-O
Raw	B-O
Images.	B-O
Uncropped	B-O
wetern	B-O
blots	B-O
from	B-O
all	B-O
main	B-O
and	B-O
supporting	B-O
information	B-O
figures.	B-O
(PDF)	B-O
Acknowledgments	B-O
We	B-O
wish	B-O
to	B-O
thank	B-O
Aruna	B-O
Balgi	B-O
for	B-O
her	B-O
technical	B-O
support.	B-O
